Take5Care+ 0.1
Research type
Research Study
Full title
Take5Care+: A self-management educational intervention to support haematology patients’ journey following a neoplastic diagnosis.
IRAS ID
368667
Contact name
Jitka Vseteckova
Contact email
Sponsor organisation
Open University
Clinicaltrials.gov Identifier
1257, Sponsor ethical approval reference
Duration of Study in the UK
1 years, 4 months, 29 days
Research summary
Patients who are diagnosed with haematological malignancies may feel that they have little or no control over their health which can be distressing. However, a diagnosis can also be the opportunity for a “teachable moment” during which patients are more likely to open to behaviour change, which can positively impact on their health and wellbeing. Take Five to Age Well was designed to empower people to achieve effective, long-term self-management of health by introducing healthy habits in 30 days.
In collaboration with Northampton General Hospital (NGH) the current study will recruit newly diagnosed haematology patients who are either being actively monitored or only on non-intensive treatment to take part in a self-managed behaviour change intervention (Take5Care+). This is primarily a feasibility study to inform main trials in the future.
The main aim of the research is:
1. To assess the feasibility of using Take5Care+ with patients newly diagnosed with indolent or chronic haematological malignancies, recruited via hospital departments
There are also secondary aims, including:
2. To assess the impact of participating in Take5Care+ on patients’ self-reported health and well-being, healthy behaviours and sense of control, knowledge and management of health
3. To explore the perceptions of patients and clinicians about their participation in the Take5Care+
Patients who wish to take part will be asked to fill out a survey at baseline, complete a “challenge” (Take5Care+) where they commit to a healthy action for 30 days, fill out a second survey immediately after and a third survey three months later. Patients may also consent to participating in an interview post-challenge. Giving consent and completing the baseline survey will take place in NGH but the challenge is self-managed at home and remotely supported. Survey 2, Survey 3 and the optional interviews are also carried out online or over the phone.REC name
West Midlands - Black Country Research Ethics Committee
REC reference
26/WM/0085
Date of REC Opinion
14 May 2026
REC opinion
Further Information Favourable Opinion